Pharmaroth Net Income Per Share from 2010 to 2026
| ROTH Stock | USD 0.0001 0.00 0.00% |
Net Loss | First Reported 2010-12-31 | Previous Quarter (0.0002) | Current Value (0.0002) | Quarterly Volatility 0.00059523 |
Check Pharmaroth Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmaroth Labs' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 154.1 K or Total Revenue of 219.2 K, as well as many indicators such as Price To Sales Ratio of 10.56, Dividend Yield of 0.0 or Days Sales Outstanding of 193. Pharmaroth financial statements analysis is a perfect complement when working with Pharmaroth Labs Valuation or Volatility modules.
Pharmaroth | Net Income Per Share | Build AI portfolio with Pharmaroth Stock |
The Net Income Per Share trend for Pharmaroth Labs offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Pharmaroth Labs is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Pharmaroth Labs' Net Income Per Share Growth Pattern
Below is the plot of the Net Income Per Share of Pharmaroth Labs over the last few years. It is Pharmaroth Labs' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharmaroth Labs' overall financial position and show how it may be relating to other accounts over time.
| Net Income Per Share | 10 Years Trend |
|
Net Income Per Share |
| Timeline |
Pharmaroth Net Income Per Share Regression Statistics
| Arithmetic Mean | (0.0006) | |
| Coefficient Of Variation | (106.67) | |
| Mean Deviation | 0.0005 | |
| Median | (0.0002) | |
| Standard Deviation | 0.0006 | |
| Sample Variance | 0.00000035 | |
| Range | 0.0018 | |
| R-Value | 0.64 | |
| Mean Square Error | 0.00000022 | |
| R-Squared | 0.41 | |
| Significance | 0.01 | |
| Slope | 0.000075 | |
| Total Sum of Squares | 0.00000567 |
Pharmaroth Net Income Per Share History
About Pharmaroth Labs Financial Statements
Investors use fundamental indicators, such as Pharmaroth Labs' Net Income Per Share, to determine how well the company is positioned to perform in the future. Although Pharmaroth Labs' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Pharmaroth Labs Correlation against competitors. For more detail on how to invest in Pharmaroth Stock please use our How to Invest in Pharmaroth Labs guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is there potential for Biotechnology market expansion? Will Pharmaroth introduce new products? Factors like these will boost the valuation of Pharmaroth Labs. Anticipated expansion of Pharmaroth directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Pharmaroth Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pharmaroth Labs is measured differently than its book value, which is the value of Pharmaroth that is recorded on the company's balance sheet. Investors also form their own opinion of Pharmaroth Labs' value that differs from its market value or its book value, called intrinsic value, which is Pharmaroth Labs' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Pharmaroth Labs' market value can be influenced by many factors that don't directly affect Pharmaroth Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Pharmaroth Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pharmaroth Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Pharmaroth Labs' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.